InvestorsHub Logo

H2R

Followers 41
Posts 2214
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: ACTcrazy post# 172

Friday, 03/01/2019 11:33:28 AM

Friday, March 01, 2019 11:33:28 AM

Post# of 196
I agree ACTcrazy.

They have had a really good run, and given they had a positive nod and that it would be the first and only "specific reversal agent available in Europe to address life-threatening bleeding associated with the use of apixaban or rivaroxaban", I expect a CHMP approval.

Best of luck with your investments!